683 Capital Management’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $148K | Sell |
|
|||||
|
2023
Q4 | $471K | Sell |
|
|||||
|
2023
Q3 | $808K | Sell |
|
|||||
|
2023
Q2 | $2.64M | Sell |
|
|||||
|
2023
Q1 | $3.54M | Buy |
|
|||||
|
2022
Q4 | $3.68M | Sell |
|
|||||
|
2022
Q3 | $32.6M | Buy |
|
|||||
|
2022
Q2 | $24.4M | Buy |
|
|||||
|
2022
Q1 | $28M | Buy |
|
|||||
|
2021
Q4 | $17.1M | Buy |
|
|||||
|
2021
Q3 | $21.2M | Buy |
|
|||||
|
2021
Q2 | $25.1M | Buy |
|
|||||
|
2021
Q1 | $23.8M | Hold |
|
|||||
|
2020
Q4 | $33M | Buy |
|
|||||
|
2020
Q3 | $21.4M | Buy |
|
|||||
|
2020
Q2 | $20.7M | Buy |
|
|||||
|
2020
Q1 | $13.9M | Buy |
|
|||||
|
2019
Q4 | $27.6M | Sell |
|
|||||
|
2019
Q3 | $19.1M | Buy |
|
|||||
|
2019
Q2 | $19.5M | Buy |
|
|||||
|
2019
Q1 | $22.5M | Hold |
|
|||||
|
2018
Q4 | $16.4M | Buy |
|
|||||
|
2018
Q3 | $7.58M | Buy |
|
|||||
|
2018
Q2 | $3.6M | Buy |
|
|||||
|
2018
Q1 | $1.92M | Buy |
|